Why do migraineurs abuse butalbital-containing combination analgesics?

Headache

Volumn 50, Issue 7, 2010, Pages 1194-1197

  Evans, Randolph W ^a   Baskin, Steven M ^a  

^a NONE

Author keywords

butalbital containing combination medications; Fiorinal; medication overuse headache; migraine; rebound headache

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS BUTALBITAL PLUS CAFFEINE; ANALGESIC AGENT; BARBITAL; BUTALBITAL; CAFFEINE; DIHYDROERGOTAMINE; PARACETAMOL; PENTOBARBITAL; PROPRANOLOL; RIZATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; VENLAFAXINE;

ADULT; ANXIETY; BORDERLINE STATE; CASE REPORT; COMORBIDITY; DRUG ACTIVITY; DRUG CONTROL; DRUG DEPENDENCE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG POTENCY; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; DRUG TOLERANCE; EMOTIONAL STRESS; EUPHORIA; FEMALE; HEADACHE; HUMAN; MENTAL DISEASE; MIGRAINE; NOTE; OUTPATIENT; PERSONALITY DISORDER; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOPATHY; RECURRENT DISEASE; RISK ASSESSMENT; TENSION HEADACHE; TREATMENT OUTCOME;

ADULT; ANALGESICS, NON-NARCOTIC; BARBITURATES; DRUG COMBINATIONS; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MIGRAINE DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 77955673668     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01725.x     Document Type: Note

References (25)

1. Solomon S. Butalbital-containing agents: Should they be banned? No. Curr Pain Headache Rep. 2002 6:147 150.
2. Silberstein SD, McCrory DC. Butalbital in the treatment of headache: History, pharmacology, and efficacy. Headache. 2001 41:953 967.
3. Young WB, Siow HC. Should butalbital-containing analgesics be banned? Yes. Curr Pain Headache Rep. 2002 6:151 155.
4. Bigal ME, Borucho S, Serrano D, Lipton RB. The acute treatment of episodic and chronic migraine in the USA. Cephalalgia. 2009 29:891 897.
5. Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache. 2006 46:766 772.
6. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998 38:497 506.
7. Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology. 2008 71:1821 1828.
8. Bigal ME, Lipton RB. Excessive opioid use and the development of chronic migraine. Pain. 2009 142:179 182.
9. Romero CE, Baron JD, Knox AP, Hinchey JA, Ropper AH. Barbiturate withdrawal following internet purchase of Fioricet. Arch Neurol. 2004 61:1111 1112.
10. Evans RW. Fiorinal fugax. Headache. 2000 40:328.
11. Cooper JR, ed. Sedative-Hypnotic Drugs: Risks and Benefits. US Department of Health, Education, and Welfare Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, Washington, DC:National Institute on Drug Abuse 1977.
12. McLean W, Boucher EA, Brennan M, et al. Is there an indication for the use of barbiturate-containing analgesic agents in the treatment of pain? Guidelines for their safe use and withdrawal management. Can J Clin Pharmacol. 2000 7:191 197.
13. Sellers EM, Hoornweg K, Busto UE, Romach MK. Risk of drug dependence and abuse posed by barbiturate-containing analgesics. Can J Clin Pharmacol. 1999 6:18 25.
14. Atasoy HT, Atasoy N, Unal AE, Emre U, Sumer M. Psychiatric comorbidity in medication overuse headache patients with preexisting headache type of episodic tension type headache. Eur J Pain. 2005 9:285 291.
15. Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005 25:519 522.
16. Rothrock J, Lopez I, Zweilfer R, et al. Borderline personality disorder and migraine. Headache. 2007 47:22 26.
17. Feldman RS, Meyer JS, Quenzer LF. Sedative-hypnotic and anxiolytic drugs. In:Feldman RS, Meyer JS, Quenzer LF, eds. Principles of Neuropsychopharmacology. Sunderland, MA:Sinauer 1997:678 686.
18. Drost ML, Walter L. Blood and plasma concentrations of butalbital following single oral doses in man. J Anal Toxicol. 1988 12:322 324.
19. Friedman AP, DiSerio FJ. Symptomatic treatment of chronically recurring tension headache: A placebo-controlled, multicenter investigation of Fioricet and acetaminophen with codeine. Clin Ther. 1987 10:69 81.
20. Holroyd KA, Malinoski P, Davis MK, Lipchik GL. The three dimensions of headache impact: Pain, disability, and affective distress. Pain. 1999 83:571 578.
21. Holm JE, Lokken C, Myers TC. Migraine and stress: A daily examination of temporal relationships in women migraineurs. Headache. 1997 37:553 558.
22. Baskin SM, Lipchik GL, Smitherman TA. Mood and anxiety disorders in chronic headache. Headache. 2006 46 (Suppl. 3 S76 S87.
23. Hamelsky SW, Lipton RB. Psychiatric comorbidity of migraine. Headache. 2006 46:1327 1333.
24. Baskin SM. Managing the "difficult" headache patient. Neurol Sci. 2007 28:S1 S5.
25. Lake AE. Medication overuse headache: Biobehavioral issues and solutions. Headache. 2006 46 (Suppl. 3 S88 S97.